Bernstein SocGen Group Upgrades Edwards Lifesciences (EW) to Market Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Bernstein SocGen Group Upgrades Edwards Lifesciences (EW) to Market Perform

Edwards Lifesciences Reports Third Quarter Results

October 24, 2024 4:21 PM EDT

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Sept. 30, 2024.

Highlights and Outlook

Q3 sales from continuing operations grew 9%; constant currency1 sales grew 10% Q3 TAVR sales grew 6%; constant currency1 sales grew 7% TMTT sales grew 73%; PASCAL and EVOQUE commercial launches continue to progress well Q3 EPS of $5.13; adjusted1 EPS of $0.67 Completed sale of Critical Care in Q3, resulting in significant one-time gain Pivotal TAVR and TMTT... More

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman

October 24, 2024 1:37 PM EDT

EW Investors with Losses Encouraged to Contact the Firm

SAN FRANCISCO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now.

Class Period: Feb. 6, 2024 July 24, 2024
Lead Plaintiff Deadline: Dec. 13, 2024
Visit:... More